Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release Mar 19 2024

· Issued by Aurobindo Pharma Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-19-2024-4

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 19, 2024, titled "Aurobindo Pharma receives USFDA Approval for Mometasone Furoate Monohydrate Nasal Spray 50 mcg/spray ".

View Attachment

6ix hasn’t read this filing yet.

Aurobindo Pharma Ltd on 6ix

Earlier from Aurobindo Pharma

Later from Aurobindo Pharma

All Aurobindo Pharma news releases